News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,529 Results
Type
Article (61260)
Company Profile (69)
Press Release (583200)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173566)
Career Advice (2729)
Deals (32403)
Drug Delivery (97)
Drug Development (76793)
Employer Resources (150)
FDA (14929)
Job Trends (13881)
News (304652)
Policy (28922)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43118)
ALS (88)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (110)
Approvals (14944)
Artificial intelligence (266)
Autoimmune disease (24)
Automation (15)
Bankruptcy (290)
Best Places to Work (10854)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (274)
Cancer (2193)
Cardiovascular disease (165)
Career advice (2312)
Career pathing (33)
CAR-T (155)
Cell therapy (432)
Cervical cancer (20)
Clinical research (62462)
Collaboration (790)
Company closure (1)
Compensation (332)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (261)
Cystic fibrosis (100)
Data (2163)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (253)
Diagnostics (6153)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60071)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94358)
Executive appointments (768)
FDA (16197)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (110)
Generative AI (20)
Gene therapy (300)
GLP-1 (666)
Government (4458)
Grass and pollen (6)
Guidances (72)
Healthcare (18202)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14782)
IRA (38)
Job creations (3411)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (505)
Leadership (22)
Legal (6430)
Liver cancer (70)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (278)
MASH (64)
Medical device (12658)
Medtech (12663)
Mergers & acquisitions (18199)
Metabolic disorders (635)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1838)
NextGen: Class of 2025 (6373)
Non-profit (4315)
Now hiring (12)
Obesity (322)
Opinion (232)
Ovarian cancer (72)
Pain (91)
Pancreatic cancer (81)
Parkinson's disease (141)
Partnered (21)
Patents (235)
Patient recruitment (112)
Peanut (50)
People (59549)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19660)
Phase II (27562)
Phase III (20126)
Pipeline (1151)
Policy (126)
Postmarket research (2468)
Preclinical (8391)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (5984)
Recruiting (61)
Regulatory (20092)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3341)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (27)
The Weekly (32)
Vaccines (664)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (125)
Last 7 days (848)
Last 30 days (2426)
Last 365 days (30456)
2025 (10279)
2024 (32266)
2023 (36327)
2022 (46615)
2021 (51562)
2020 (50711)
2019 (44765)
2018 (34053)
2017 (30710)
2016 (30055)
2015 (35429)
2014 (28373)
2013 (24947)
2012 (26213)
2011 (26455)
2010 (24928)
Location
Africa (871)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38049)
Australia (6847)
California (5587)
Canada (1859)
China (487)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (88567)
Florida (851)
Georgia (200)
Idaho (56)
Illinois (550)
India (25)
Indiana (281)
Iowa (10)
Japan (155)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (832)
Massachusetts (4034)
Michigan (223)
Minnesota (339)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1650)
New Mexico (29)
New York (1641)
North Carolina (959)
North Dakota (9)
Northern California (2421)
Ohio (195)
Oklahoma (15)
Oregon (36)
Pennsylvania (1236)
Puerto Rico (12)
Rhode Island (31)
South America (1176)
South Carolina (17)
South Dakota (1)
Southern California (2140)
Tennessee (96)
Texas (853)
United States (21339)
Utah (175)
Virginia (143)
Washington D.C. (51)
Washington State (512)
West Virginia (3)
Wisconsin (60)
644,529 Results for "university of leipzig".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
RNA delivery and therapeutics company SiSaf Ltd announces its collaboration with the University of Leipzig, Germany, to develop Bio-Courier targeted micro interfering RNAs for the treatment of cancer, with an initial focus on pancreatic cancer.
March 2, 2023
·
4 min read
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
InspireMD, Inc. today announced the presentation of positive one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Carotid Stent System for the treatment of carotid artery stenosis at this year’s Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.
May 28, 2024
·
8 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
BioMidwest
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
InspireMD, Inc. announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course 2024, which is being held May 28-31, in Leipzig, Germany.
March 26, 2024
·
7 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
Press Releases
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
January 15, 2025
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
1 of 64,453
Next
